Rallybio Corp
(NASDAQ:RLYB)
$6.78
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Day Range- - -52 Wk Range4.540 - 15.890Open / Close- / -Float / Outstanding31.236M / 37.838M
Vol / Avg.0 / 118.801KMkt Cap256.544MP/E-50d Avg. Price6.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float31.236MEPS-2.050

Rallybio Stock (NASDAQ:RLYB), Quotes and News Summary

Rallybio Stock (NASDAQ: RLYB) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range4.540 - 15.890Open / Close- / -Float / Outstanding31.236M / 37.838M
Vol / Avg.0 / 118.801KMkt Cap256.544MP/E-50d Avg. Price6.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float31.236MEPS-2.050
Business Wire - Nov 10, 2022, 9:15AM
Business Wire - May 10, 2022, 8:00AM
TipRanks - Dec 1, 2022, 12:45PM
InvestorsObserver - Nov 15, 2022, 1:11PM
Seeking Alpha - Nov 11, 2022, 4:58AM
Seeking Alpha - Nov 10, 2022, 9:59AM
TipRanks - Jul 25, 2022, 12:25AM
Sector: Health Care.Industry: Biotechnology
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-14
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.600 -0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Rallybio (RLYB) stock?

A

You can purchase shares of Rallybio (NASDAQ: RLYB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Rallybio's (RLYB) competitors?

Q

What is the target price for Rallybio (RLYB) stock?

A

The latest price target for Rallybio (NASDAQ: RLYB) was reported by JP Morgan on Friday, December 9, 2022. The analyst firm set a price target for 21.00 expecting RLYB to rise to within 12 months (a possible 209.73% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Rallybio (RLYB)?

A

The stock price for Rallybio (NASDAQ: RLYB) is $6.78 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Rallybio (RLYB) pay a dividend?

A

There are no upcoming dividends for Rallybio.

Q

When is Rallybio (NASDAQ:RLYB) reporting earnings?

A

Rallybio’s Q4 earnings are confirmed for Tuesday, March 14, 2023.

Q

Is Rallybio (RLYB) going to split?

A

There is no upcoming split for Rallybio.

Q

What sector and industry does Rallybio (RLYB) operate in?

A

Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rallybio Stock (NASDAQ:RLYB), Quotes and News Summary

Rallybio Stock (NASDAQ: RLYB) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range4.540 - 15.890Open / Close- / -Float / Outstanding31.236M / 37.838M
Vol / Avg.0 / 118.801KMkt Cap256.544MP/E-50d Avg. Price6.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float31.236MEPS-2.050
Business Wire - Nov 10, 2022, 9:15AM
Business Wire - May 10, 2022, 8:00AM
TipRanks - Dec 1, 2022, 12:45PM
InvestorsObserver - Nov 15, 2022, 1:11PM
Seeking Alpha - Nov 11, 2022, 4:58AM
Seeking Alpha - Nov 10, 2022, 9:59AM
TipRanks - Jul 25, 2022, 12:25AM
Sector: Health Care.Industry: Biotechnology
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-14
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.600 -0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Rallybio (RLYB) stock?

A

You can purchase shares of Rallybio (NASDAQ: RLYB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Rallybio's (RLYB) competitors?

Q

What is the target price for Rallybio (RLYB) stock?

A

The latest price target for Rallybio (NASDAQ: RLYB) was reported by JP Morgan on Friday, December 9, 2022. The analyst firm set a price target for 21.00 expecting RLYB to rise to within 12 months (a possible 209.73% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Rallybio (RLYB)?

A

The stock price for Rallybio (NASDAQ: RLYB) is $6.78 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Rallybio (RLYB) pay a dividend?

A

There are no upcoming dividends for Rallybio.

Q

When is Rallybio (NASDAQ:RLYB) reporting earnings?

A

Rallybio’s Q4 earnings are confirmed for Tuesday, March 14, 2023.

Q

Is Rallybio (RLYB) going to split?

A

There is no upcoming split for Rallybio.

Q

What sector and industry does Rallybio (RLYB) operate in?

A

Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rallybio Stock (NASDAQ:RLYB), Quotes and News Summary

Rallybio Stock (NASDAQ: RLYB) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range4.540 - 15.890Open / Close- / -Float / Outstanding31.236M / 37.838M
Vol / Avg.0 / 118.801KMkt Cap256.544MP/E-50d Avg. Price6.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float31.236MEPS-2.050
Business Wire - Nov 10, 2022, 9:15AM
Business Wire - May 10, 2022, 8:00AM
TipRanks - Dec 1, 2022, 12:45PM
InvestorsObserver - Nov 15, 2022, 1:11PM
Seeking Alpha - Nov 11, 2022, 4:58AM
Seeking Alpha - Nov 10, 2022, 9:59AM
TipRanks - Jul 25, 2022, 12:25AM
Sector: Health Care.Industry: Biotechnology
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-14
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.600 -0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Rallybio (RLYB) stock?

A

You can purchase shares of Rallybio (NASDAQ: RLYB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Rallybio's (RLYB) competitors?

Q

What is the target price for Rallybio (RLYB) stock?

A

The latest price target for Rallybio (NASDAQ: RLYB) was reported by JP Morgan on Friday, December 9, 2022. The analyst firm set a price target for 21.00 expecting RLYB to rise to within 12 months (a possible 209.73% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Rallybio (RLYB)?

A

The stock price for Rallybio (NASDAQ: RLYB) is $6.78 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Rallybio (RLYB) pay a dividend?

A

There are no upcoming dividends for Rallybio.

Q

When is Rallybio (NASDAQ:RLYB) reporting earnings?

A

Rallybio’s Q4 earnings are confirmed for Tuesday, March 14, 2023.

Q

Is Rallybio (RLYB) going to split?

A

There is no upcoming split for Rallybio.

Q

What sector and industry does Rallybio (RLYB) operate in?

A

Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rallybio Stock (NASDAQ:RLYB), Quotes and News Summary

Rallybio Stock (NASDAQ: RLYB) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range4.540 - 15.890Open / Close- / -Float / Outstanding31.236M / 37.838M
Vol / Avg.0 / 118.801KMkt Cap256.544MP/E-50d Avg. Price6.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float31.236MEPS-2.050
Business Wire - Nov 10, 2022, 9:15AM
Business Wire - May 10, 2022, 8:00AM
TipRanks - Dec 1, 2022, 12:45PM
InvestorsObserver - Nov 15, 2022, 1:11PM
Seeking Alpha - Nov 11, 2022, 4:58AM
Seeking Alpha - Nov 10, 2022, 9:59AM
TipRanks - Jul 25, 2022, 12:25AM
Sector: Health Care.Industry: Biotechnology
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-14
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.600 -0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Rallybio (RLYB) stock?

A

You can purchase shares of Rallybio (NASDAQ: RLYB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Rallybio's (RLYB) competitors?

Q

What is the target price for Rallybio (RLYB) stock?

A

The latest price target for Rallybio (NASDAQ: RLYB) was reported by JP Morgan on Friday, December 9, 2022. The analyst firm set a price target for 21.00 expecting RLYB to rise to within 12 months (a possible 209.73% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Rallybio (RLYB)?

A

The stock price for Rallybio (NASDAQ: RLYB) is $6.78 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Rallybio (RLYB) pay a dividend?

A

There are no upcoming dividends for Rallybio.

Q

When is Rallybio (NASDAQ:RLYB) reporting earnings?

A

Rallybio’s Q4 earnings are confirmed for Tuesday, March 14, 2023.

Q

Is Rallybio (RLYB) going to split?

A

There is no upcoming split for Rallybio.

Q

What sector and industry does Rallybio (RLYB) operate in?

A

Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rallybio Stock (NASDAQ:RLYB), Quotes and News Summary

Rallybio Stock (NASDAQ: RLYB) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range4.540 - 15.890Open / Close- / -Float / Outstanding31.236M / 37.838M
Vol / Avg.0 / 118.801KMkt Cap256.544MP/E-50d Avg. Price6.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float31.236MEPS-2.050
Business Wire - Nov 10, 2022, 9:15AM
Business Wire - May 10, 2022, 8:00AM
TipRanks - Dec 1, 2022, 12:45PM
InvestorsObserver - Nov 15, 2022, 1:11PM
Seeking Alpha - Nov 11, 2022, 4:58AM
Seeking Alpha - Nov 10, 2022, 9:59AM
TipRanks - Jul 25, 2022, 12:25AM
Sector: Health Care.Industry: Biotechnology
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-14
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.600 -0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Rallybio (RLYB) stock?

A

You can purchase shares of Rallybio (NASDAQ: RLYB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Rallybio's (RLYB) competitors?

Q

What is the target price for Rallybio (RLYB) stock?

A

The latest price target for Rallybio (NASDAQ: RLYB) was reported by JP Morgan on Friday, December 9, 2022. The analyst firm set a price target for 21.00 expecting RLYB to rise to within 12 months (a possible 209.73% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Rallybio (RLYB)?

A

The stock price for Rallybio (NASDAQ: RLYB) is $6.78 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Rallybio (RLYB) pay a dividend?

A

There are no upcoming dividends for Rallybio.

Q

When is Rallybio (NASDAQ:RLYB) reporting earnings?

A

Rallybio’s Q4 earnings are confirmed for Tuesday, March 14, 2023.

Q

Is Rallybio (RLYB) going to split?

A

There is no upcoming split for Rallybio.

Q

What sector and industry does Rallybio (RLYB) operate in?

A

Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rallybio Stock (NASDAQ:RLYB), Quotes and News Summary

Rallybio Stock (NASDAQ: RLYB) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range4.540 - 15.890Open / Close- / -Float / Outstanding31.236M / 37.838M
Vol / Avg.0 / 118.801KMkt Cap256.544MP/E-50d Avg. Price6.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float31.236MEPS-2.050
Business Wire - Nov 10, 2022, 9:15AM
Business Wire - May 10, 2022, 8:00AM
TipRanks - Dec 1, 2022, 12:45PM
InvestorsObserver - Nov 15, 2022, 1:11PM
Seeking Alpha - Nov 11, 2022, 4:58AM
Seeking Alpha - Nov 10, 2022, 9:59AM
TipRanks - Jul 25, 2022, 12:25AM
Sector: Health Care.Industry: Biotechnology
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-14
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.600 -0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Rallybio (RLYB) stock?

A

You can purchase shares of Rallybio (NASDAQ: RLYB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Rallybio's (RLYB) competitors?

Q

What is the target price for Rallybio (RLYB) stock?

A

The latest price target for Rallybio (NASDAQ: RLYB) was reported by JP Morgan on Friday, December 9, 2022. The analyst firm set a price target for 21.00 expecting RLYB to rise to within 12 months (a possible 209.73% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Rallybio (RLYB)?

A

The stock price for Rallybio (NASDAQ: RLYB) is $6.78 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Rallybio (RLYB) pay a dividend?

A

There are no upcoming dividends for Rallybio.

Q

When is Rallybio (NASDAQ:RLYB) reporting earnings?

A

Rallybio’s Q4 earnings are confirmed for Tuesday, March 14, 2023.

Q

Is Rallybio (RLYB) going to split?

A

There is no upcoming split for Rallybio.

Q

What sector and industry does Rallybio (RLYB) operate in?

A

Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rallybio Stock (NASDAQ:RLYB), Quotes and News Summary

Rallybio Stock (NASDAQ: RLYB) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range4.540 - 15.890Open / Close- / -Float / Outstanding31.236M / 37.838M
Vol / Avg.0 / 118.801KMkt Cap256.544MP/E-50d Avg. Price6.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float31.236MEPS-2.050
Business Wire - Nov 10, 2022, 9:15AM
Business Wire - May 10, 2022, 8:00AM
TipRanks - Dec 1, 2022, 12:45PM
InvestorsObserver - Nov 15, 2022, 1:11PM
Seeking Alpha - Nov 11, 2022, 4:58AM
Seeking Alpha - Nov 10, 2022, 9:59AM
TipRanks - Jul 25, 2022, 12:25AM
Sector: Health Care.Industry: Biotechnology
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-14
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.600 -0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Rallybio (RLYB) stock?

A

You can purchase shares of Rallybio (NASDAQ: RLYB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Rallybio's (RLYB) competitors?

Q

What is the target price for Rallybio (RLYB) stock?

A

The latest price target for Rallybio (NASDAQ: RLYB) was reported by JP Morgan on Friday, December 9, 2022. The analyst firm set a price target for 21.00 expecting RLYB to rise to within 12 months (a possible 209.73% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Rallybio (RLYB)?

A

The stock price for Rallybio (NASDAQ: RLYB) is $6.78 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Rallybio (RLYB) pay a dividend?

A

There are no upcoming dividends for Rallybio.

Q

When is Rallybio (NASDAQ:RLYB) reporting earnings?

A

Rallybio’s Q4 earnings are confirmed for Tuesday, March 14, 2023.

Q

Is Rallybio (RLYB) going to split?

A

There is no upcoming split for Rallybio.

Q

What sector and industry does Rallybio (RLYB) operate in?

A

Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rallybio Stock (NASDAQ:RLYB), Quotes and News Summary

Rallybio Stock (NASDAQ: RLYB) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range4.540 - 15.890Open / Close- / -Float / Outstanding31.236M / 37.838M
Vol / Avg.0 / 118.801KMkt Cap256.544MP/E-50d Avg. Price6.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float31.236MEPS-2.050
Business Wire - Nov 10, 2022, 9:15AM
Business Wire - May 10, 2022, 8:00AM
TipRanks - Dec 1, 2022, 12:45PM
InvestorsObserver - Nov 15, 2022, 1:11PM
Seeking Alpha - Nov 11, 2022, 4:58AM
Seeking Alpha - Nov 10, 2022, 9:59AM
TipRanks - Jul 25, 2022, 12:25AM
Sector: Health Care.Industry: Biotechnology
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-14
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.600 -0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Rallybio (RLYB) stock?

A

You can purchase shares of Rallybio (NASDAQ: RLYB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Rallybio's (RLYB) competitors?

Q

What is the target price for Rallybio (RLYB) stock?

A

The latest price target for Rallybio (NASDAQ: RLYB) was reported by JP Morgan on Friday, December 9, 2022. The analyst firm set a price target for 21.00 expecting RLYB to rise to within 12 months (a possible 209.73% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Rallybio (RLYB)?

A

The stock price for Rallybio (NASDAQ: RLYB) is $6.78 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Rallybio (RLYB) pay a dividend?

A

There are no upcoming dividends for Rallybio.

Q

When is Rallybio (NASDAQ:RLYB) reporting earnings?

A

Rallybio’s Q4 earnings are confirmed for Tuesday, March 14, 2023.

Q

Is Rallybio (RLYB) going to split?

A

There is no upcoming split for Rallybio.

Q

What sector and industry does Rallybio (RLYB) operate in?

A

Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rallybio Stock (NASDAQ:RLYB), Quotes and News Summary

Rallybio Stock (NASDAQ: RLYB) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range4.540 - 15.890Open / Close- / -Float / Outstanding31.236M / 37.838M
Vol / Avg.0 / 118.801KMkt Cap256.544MP/E-50d Avg. Price6.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float31.236MEPS-2.050
Business Wire - Nov 10, 2022, 9:15AM
Business Wire - May 10, 2022, 8:00AM
TipRanks - Dec 1, 2022, 12:45PM
InvestorsObserver - Nov 15, 2022, 1:11PM
Seeking Alpha - Nov 11, 2022, 4:58AM
Seeking Alpha - Nov 10, 2022, 9:59AM
TipRanks - Jul 25, 2022, 12:25AM
Sector: Health Care.Industry: Biotechnology
Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-14
REV
Q3 2022Est.ActualSurprise
EPS-0.540-0.600 -0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Rallybio (RLYB) stock?

A

You can purchase shares of Rallybio (NASDAQ: RLYB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Rallybio's (RLYB) competitors?

Q

What is the target price for Rallybio (RLYB) stock?

A

The latest price target for Rallybio (NASDAQ: RLYB) was reported by JP Morgan on Friday, December 9, 2022. The analyst firm set a price target for 21.00 expecting RLYB to rise to within 12 months (a possible 209.73% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Rallybio (RLYB)?

A

The stock price for Rallybio (NASDAQ: RLYB) is $6.78 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Rallybio (RLYB) pay a dividend?

A

There are no upcoming dividends for Rallybio.

Q

When is Rallybio (NASDAQ:RLYB) reporting earnings?

A

Rallybio’s Q4 earnings are confirmed for Tuesday, March 14, 2023.

Q

Is Rallybio (RLYB) going to split?

A

There is no upcoming split for Rallybio.

Q

What sector and industry does Rallybio (RLYB) operate in?

A

Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.